New article: The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy. https://t.co/QaRIGnJEQg #CLL #leusm #hematology
Proud of my wife continuing to push the envelope.
Great work led by Dr. @UjjaniC
Check out our newest publication! The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy @anthonymatomd @mshadman @LRoekerMD @SeattleCCA @fredhutch https://t.co/yQqUPauy7J
RT @DrRaulCordoba: #OncoAlert The Impact of Age on Survival in #CLL Patients Receiving #Ibrutinib as Initial Therapy #CLLsm #leusm #lymsm #…
#OncoAlert The Impact of Age on Survival in #CLL Patients Receiving #Ibrutinib as Initial Therapy #CLLsm #leusm #lymsm #gerionc #geriheme https://t.co/b6FSOmd8d0
RT @anthonymatomd: New data! The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as I | BLCTT @UjjaniC and colleagues @slo…